e-learning
resources
Amsterdam 2011
Sunday, 25.09.2011
Bronchodilators in asthma and COPD
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Influence of tiotropium bromid on airway inflammation and symptom in COPD patients
D. Ozol, H. Karaman, R. Akgedik, S. Uysal, R. Yigitoglu, Z. Yildirim (Ankara, Turkey)
Source:
Annual Congress 2011 - Bronchodilators in asthma and COPD
Session:
Bronchodilators in asthma and COPD
Session type:
Thematic Poster Session
Number:
870
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
D. Ozol, H. Karaman, R. Akgedik, S. Uysal, R. Yigitoglu, Z. Yildirim (Ankara, Turkey). Influence of tiotropium bromid on airway inflammation and symptom in COPD patients. Eur Respir J 2011; 38: Suppl. 55, 870
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Related content which might interest you:
Effects of tiotropium bromide on bronchial obstruction and exercise tolerance in COPD patients
Source: Eur Respir J 2006; 28: Suppl. 50, 213s
Year: 2006
Effect of inhaled tiotropium on tracheobronchial clearance in patients with COPD
Source: Eur Respir J 2001; 18: Suppl. 33, 245s
Year: 2001
Dual bronchodilation with once-daily QVA149 reduces exacerbations, improves lung function and health status versus glycopyrronium and tiotropium in severe-to-very severe COPD patients: The SPARK study
Source: Annual Congress 2013 –New bronchodilators for COPD management
Year: 2013
Tiotropium + olodaterol in patients with moderate to severe COPD with chronic bronchitis and/or emphysema
Source: International Congress 2016 – Pharmacological treatment of COPD: focus on LABA/LAMA combinations
Year: 2016
The influence of tiotropium bromide on neutrophiles function of bronchial region in COPD patients
Source: Annual Congress 2010 - COPD: management
Year: 2010
Effect of glycopyrronium vs tiotropium on pulmonary function and morning symptoms in patients with moderate-to-severe COPD: The SPRING study
Source: International Congress 2015 – New data on established treatments for asthma and COPD
Year: 2015
Effects of ciclesonide on the management of stable COPD with airway eosinophilia
Source: Annual Congress 2013 –COPD treatment and others
Year: 2013
Effect of dupilumab on severe exacerbations in asthma patients with and without lung function improvements
Source: Virtual Congress 2020 – Monoclonal antibodies; randomised controlled trials and real-world studies in asthma
Year: 2020
Assessing bronchodilator response in patients with asthma and COPD using 19F-MRI
Source: Virtual Congress 2020 – New imaging techniques applied to old problems
Year: 2020
Bronchodilator responsiveness in patients with COPD
Source: Eur Respir J 2008; 31: 742-750
Year: 2008
Effects of regular formoterol treatment on airway hyperresponsiveness in patients with mild to moderate asthma
Source: Eur Respir J 2003; 22: Suppl. 45, 285s
Year: 2003
The effect of salmeterol/fluticasone on markers of airway inflammation in patients with uncontrolled asthma
Source: Annual Congress 2012 - Asthma treatment: efficacy and safety
Year: 2012
Effects of fluticasone and ciclesonide on pulmonary function and airway inflammation in stable mild asthmatics
Source: Annual Congress 2009 - Aspects of clinical asthma
Year: 2009
Patterns of bronchodilator reversibility of FEV1 in asthma and COPD patients
Source: Annual Congress 2012 - Translational respiratory medicine in asthma and COPD
Year: 2012
The effect of tiotropium in COPD complicated with asthma
Source: Annual Congress 2007 - New insights into the treatment of COPD
Year: 2007
Effects of adding salmeterol to inhaled corticosteroids on lung function and quality of life in patients with mild persistent asthma
Source: Eur Respir J 2006; 28: Suppl. 50, 499s
Year: 2006
Influence of tiotropium bromide and formoterol on bronchial hyperresponsiveness in COPD
Source: Annual Congress 2012 - COPD treatment and varia
Year: 2012
Evaluation of the response of airway obstruction to short-acting inhaled broncodilators with using FIV
1
and FEV
1
in COPD patients
Source: Eur Respir J 2005; 26: Suppl. 49, 290s
Year: 2005
Bronchodilator efficacy of tiotropium in patients with mild COPD
Source: Eur Respir J 2006; 28: Suppl. 50, 616s
Year: 2006
Effect of aclidinium bromide on static lung function and hyperinflation in patients with moderate to severe COPD
Source: Annual Congress 2013 –LAMA, LABA, ICS and their combinations for the treatment of asthma and COPD
Year: 2013
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept